Developing histone deacetylase inhibitors in the therapeutic armamentarium of pancreatic adenocarcinoma

Author： Zafar Syed F Nagaraju Ganji Purnachandra El-Rayes Bassel

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.16, Iss.7, 2012-07, pp. : 707-718

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Application of Histone Deacetylase Inhibitors for Stroke

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 11, Iss. 2, 2011-06 ,pp. : 138-149

Bentham Science Publishers

Access to resources Recommend Favorite

Developing Histone Deacetylase Inhibitors as Anti-Cancer Therapeutics

Current Medicinal Chemistry, Vol. 18, Iss. 11, 2011-04 ,pp. : 1658-1671

Bentham Science Publishers

Access to resources Recommend Favorite

An Epigenetic Approach to Pancreatic Cancer Treatment: The Prospective Role of Histone Deacetylase Inhibitors

Current Cancer Drug Targets, Vol. 12, Iss. 4, 2012-04 ,pp. : 439-452

Bentham Science Publishers

Access to resources Recommend Favorite

Histone deacetylase inhibitors

By Price Steve Dyke Hazel J

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 7, 2007-07 ,pp. : 745-765

Informa Healthcare

Access to resources Recommend Favorite

Macrocyclic Histone Deacetylase Inhibitors

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 14, 2010-10 ,pp. : 1423-1440

Bentham Science Publishers

Access to resources Recommend Favorite